Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
The impact of retinoic acid treatment on the sensitivity of neuroblastoma cells to fenretinide
LY-2090314 shows limited efficacy as monotherapy
APX-115 protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice
3)38-23(35)19-30-12-10-29(18-22(33)34)11-13-31(20-24(36)39-27(4
6R)-3-amino-6-(aminomethyl)-5-hydroxytetrahydro-2H-pyran-2-yl)oxy)-2-hydroxycyclohexyl)oxy)-6-(hydroxymethyl)tetrahydro-2H-pyran-3
IRAK4-IN-4 - CAS# 1850276-58-2 vimopan dihydrate The impact of retinoic acidIRAK4 IN 4 is an interleukin 1 receptor associated kinase 4 (IRAK4) inhibitor extracted from patent CN107163044A, Compound15, has an IC50 of 2. 8 nM. IRAK4 IN 4 also inhibits cyclic GMP AMP synthase (cGAS) with an IC50 of 2. 1 nM. Product information CAS Number: 1850276 58 2 Molecular Weight: 340. 37 Formula: C22H16N2O2 Chemical Name: 1 {7 methyl 2 phenylimidazo[1,2 a]pyridin 3 yl} 2 phenylethane 1,2 dione Smiles:
US$ 141.26
US$ 253.12
US$ 285.79
US$ 188.90
US$ 285.79
US$ 330.00
US$ 264.00
US$ 197.42
US$ 148.00
US$ 147.58
US$ 137.54
US$ 147.58
US$ 163.90
US$ 126.47